Elisha M. Wachman, MD
Associate Professor
Boston University School of Medicine
Dept of Pediatrics
Neonatology

MD, Boston University School of Medicine




Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research interests include the genetics and epigenetics of NAS, breastfeeding in the setting of maternal substance use disorders, and the use of non-pharmacologic care methods to improve NAS outcomes. She is the neonatal lead of the Massachusetts (MA) neoQIC NAS Quality Improvement Collaborative. She was a site investigator in a NIDA funded clinical trial comparing the short-term and long-term outcomes of methadone versus morphine for NAS and is currently the principal investigator of a NICHD funded study examining the safety, efficacy, pharmacokinetics, pharmacogenomics, and long-term maternal and infant outcomes of extended-release naltrexone for pregnant women with opioid use disorder.

2018 America's Essential Hospitals Gage Award



The National Drug Abuse Treatment Clinical Trials Network (CTN-0080
06/01/2019 - 02/28/2024 (PI)
McLean Hospital NIH-NIDA

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with…
09/17/2018 - 05/31/2023 (PI)
NIH-NICHD
1R01HD096798-01

Neonatal Abstinence Syndrome (NAS) Research and Quality Improvement Program
12/14/2016 - 08/31/2018 (PI)
Massachusetts Health Policy Commission


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C, Wachman EM. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020 Aug 25; 100:69-74.View Related Profiles. PMID: 32862058
     
  2. Sen S, Andrews C, Anderson E, Turner D, Monthé-Drèze C, Wachman EM. Type of feeding provided with dextrose gel impacts hypoglycemia outcomes: comparing donor milk, formula, and breastfeeding. J Perinatol. 2020 Aug 13. PMID: 32792637
     
  3. Wachman EM, Houghton M, Melvin P, Isley BC, Murzycki J, Singh R, Minear S, MacMillan KDL, Banville D, Walker A, Mitchell T, Galimi-Hayes R, Jorgensen S, Gomes DR, Hodgins F, Whalen BL, Diop H, Gupta M. A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts' PNQIN collaborative. J Perinatol. 2020 Oct; 40(10):1560-1569.View Related Profiles. PMID: 32678314
     
  4. Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Letter-in-reply. J Addict Med. 2020 Jul/Aug; 14(4):354-355. PMID: 31972769
     
  5. Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials. 2020 Jun; 93:106014.View Related Profiles. PMID: 32353544
     
  6. Wachman EM. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome? J Addict Med. 2020 Mar/Apr; 14(2):93-94. PMID: 31149916
     
  7. Czynski AJ, Davis JM, Dansereau LM, Engelhardt B, Marro P, Bogen DL, Hudak ML, Shenberger J, Wachman EM, Oliveira EL, Lester BM. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome. J Pediatr. 2020 04; 219:146-151.e1. PMID: 31987653
     
  8. Stulac S, Bair-Merritt M, Wachman EM, Augustyn M, Howard C, Madoor N, Costello E. Children and families of the opioid epidemic: Under the radar. Curr Probl Pediatr Adolesc Health Care. 2019 08; 49(8):100637.View Related Profiles. PMID: 31494050
     
  9. Minear S, Wachman EM. Management of Newborns with Prenatal Opioid Exposure: One Institution's Journey. Clin Ther. 2019 09; 41(9):1663-1668.View Related Profiles. PMID: 31439335
     
  10. Wachman EM, Saia K, Miller M, Valle E, Shrestha H, Carter G, Werler M, Jones H. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects. Clin Ther. 2019 09; 41(9):1681-1689.View Related Profiles. PMID: 31358302
     
Showing 10 of 41 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 41 publications over 10 distinct years, with a maximum of 9 publications in 2018

YearPublications
20102
20111
20131
20142
20153
20164
20174
20189
20198
20207
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Neonatal Abstinence Syndrome
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Wachman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department